Clinical Trials Logo

Filter by:
NCT ID: NCT02981459 Withdrawn - Clinical trials for Bladder Pain Syndrome

Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women

Start date: December 8, 2017
Phase: Phase 4
Study type: Interventional

The specific purpose of this study is to provide objective data in prospective open label design (n=40) to support the use of Mirabegron as a treatment for pain related urinary frequency and urgency. Women with bladder pain have a poor response to traditional anticholinergic therapy for their symptoms of frequency and urgency.

NCT ID: NCT02981394 Withdrawn - Osteoarthritis Clinical Trials

Clinical Outcomes of Autologous Bone Marrow Aspirate Concentrate Injections for Musculoskeletal Conditions

Start date: November 2016
Phase:
Study type: Observational [Patient Registry]

The use of Bone Marrow Autologous Collection (BMAC) in musculoskeletal conditions including osteoarthritis and tendon injuries has been growing. Outcome evidence continues to be sparse. The purpose of this study is collect a longitudinal case series of patient reported outcomes following BMAC injections for musculoskeletal conditions including osteoarthritis, tendinopathy and injuries to ligaments, tendons and muscles.

NCT ID: NCT02981160 Withdrawn - Obesity Clinical Trials

Validation of a Personal Breath Analyzer for Diet and Energy Expenditure Assessment and Management

Breezing
Start date: December 2016
Phase: N/A
Study type: Interventional

The purpose of the research is to determine energy expenditure rates and diet and/ physical activity metabolic features of an individual using current state technologies and a new technology created at the Center for Bioelectronics and Biosensors at ASU. This is a pilot study which intent is to validate this device for use in the weight loss patient population. This study will involve research of metabolic physiological parameters that are measured through the breath of the individuals, together with other physical parameters (weight, height, date of birth, fat and lean body composition via bio-impedance, heart rate, blood pressure, and breathing rate) assessed in the clinic, and a questionnaire about diary physical activities. The study will involve withdrawn of breath samples at resting conditions, and under diets or physical activities regimes. This instrument will assist our patients in terms of tailoring their diet/nutrition through their weight loss journey prior and after surgery. As a new technology, it will be an excellent tool for compliance assessment and engagement with the Weight Loss Program as well as for long term follow up.

NCT ID: NCT02981017 Withdrawn - Chronic Sinusitis Clinical Trials

Improvement of Outcomes in Draf III/Endoscopic Modified Lothrop Procedure

Start date: November 1, 2016
Phase: N/A
Study type: Interventional

We propose a randomized, single-blinded, prospective trial in order to evaluate the efficacy of the Cook Biodesign ENT Repair graft in improving outcomes after the Draf III or Endoscopic Modified Lothrop procedure. The Cook Biodesign ENT Repair graft is a porcine intestinal submucosal xenograft which has been FDA approved for use as an adjunct to natural healing process in the sinonasal cavity. The Draf III or Endoscopic Modified Lothrop involved creating a large unified drainage pathway for refractory frontal sinusitis. After the procedure is completed, there is exposed bone along the frontal beak region which can become a nidus for inflammation, crusting and eventual scarring, leading to stenosis or even complete blockage of the frontal sinuses. The Cook Biodesign will be used to cover this exposed bone in order to potentially reduce the inflammation, crusting and scarring and possibly improve outcomes.

NCT ID: NCT02977741 Withdrawn - Nausea Clinical Trials

Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting

Start date: November 2016
Phase:
Study type: Observational

Prospective, observational study evaluating the effect of olanzapine for the treatment of refractory chronic nausea and vomiting.

NCT ID: NCT02977689 Withdrawn - Glioma Clinical Trials

Trial of IDH305 in IDH1 Mutant Grade II or III Glioma

Start date: April 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to found out if the drug IDH305 is safe and effective in subjects with IDH1 mutant grade II or III glioma that has progressed after observation or radiation therapy.

NCT ID: NCT02977611 Withdrawn - Iron Deficiency Clinical Trials

The Safety of a High-Dose, Rapid Infusion of Iron Sucrose

Start date: January 2017
Phase: Phase 2
Study type: Interventional

Iron sucrose infusion is an iron replacement used to treat iron deficiency anemia (not enough iron in the body to make hemoglobin). Iron is a mineral that the body needs to produce hemoglobin, which carries oxygen in the blood. When the body does not get enough iron, it cannot produce enough hemoglobin and you become anemic. The research study is looking at the side effects of using a higher dose and faster rate of iron sucrose infusion than what is used in standard of care. The purpose of this study is to see if infusion with 500 mg of iron sucrose over a one hour time period can be done safely. If this can be done safely, it may reduce the total number of infusions required and the time for each infusion. This may be less costly and less burdensome to patients.

NCT ID: NCT02977039 Withdrawn - Clinical trials for Type 2 Diabetes Mellitus in Obese

Effect of a Plant Rich Diet on in People With Type 2 Diabetes and Obesity

Start date: November 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of a nutrient dense plant rich (NDPR) diet compared to a standard USDA diet on glycemic control, inflammation, and cardiovascular risk in individuals with type 2 diabetes and overweight/obesity.

NCT ID: NCT02975999 Withdrawn - Pleural Effusion Clinical Trials

Use of Vasopressin Following the Fontan Operation

Start date: December 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.

NCT ID: NCT02975986 Withdrawn - Clinical trials for Uric Acid Nephrolithiasis

Renal Uptake of Fatty Acids (FFA) in Patients With Idiopathic Uric Acid Nephrolithiasis (IUAN)

IUAN
Start date: January 2017
Phase: N/A
Study type: Interventional

The investigators will test the hypothesis that renal uptake of free (i.e. non-esterified) fatty acids (FFa) is increased in iuan. To accomplish this goal the investigators will measure renal FFa uptake FFa uptake in vivo in patients with iuan and matched non-stone forming subjects via single-photon emission computed tomography (SPeCT)/CT imaging. The definitive proof of the hypothesis rests on whether increased renal FFa uptake is demonstrable in humans with iuan.